Literature DB >> 12975033

Nutrition therapy for diabetic gastroparesis.

Diana Gentilcore1, Deirdre O'Donovan, Karen L Jones, Michael Horowitz.   

Abstract

The management of diabetic gastroparesis often represents a significant clinical challenge in which the maintenance of nutrition is pivotal. Gastric emptying is delayed in 30% to 50% of patients with longstanding type 1 or type 2 diabetes and upper gastrointestinal symptoms also occur frequently. However, there is only a weak association between the presence of symptoms and delayed gastric emptying. Acute changes in blood glucose concentrations affect gastric motility in diabetes; hyperglycemia slows gastric emptying whereas hypoglycemia may accelerate it; blood glucose concentrations may also influence symptoms. It is now recognized that gastric emptying is a major determinant of postprandial glycemia and, therefore, there is considerable interest in the concept of modulating gastric emptying, by dietary or pharmacologic means, to optimize glycemic control in diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975033     DOI: 10.1007/s11892-003-0087-9

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  77 in total

1.  Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.

Authors:  M Chandalia; A Garg; D Lutjohann; K von Bergmann; S M Grundy; L J Brinkley
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

2.  Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects.

Authors:  K L Jones; M Berry; M F Kong; M A Kwiatek; M Samsom; M Horowitz
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

3.  Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial.

Authors:  G Stacher; G Schernthaner; M Francesconi; H P Kopp; H Bergmann; G Stacher-Janotta; U Weber
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

4.  Predictors of delayed gastric emptying in diabetes.

Authors:  K L Jones; A Russo; J E Stevens; J M Wishart; M K Berry; M Horowitz
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

5.  Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis.

Authors:  K L Jones; J M Wishart; M K Berry; J L Abitbol; M Horowitz
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

Review 6.  Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.

Authors:  M A Nauck; J J Holst; B Willms; W Schmiegel
Journal:  Exp Clin Endocrinol Diabetes       Date:  1997       Impact factor: 2.949

7.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

Authors:  Mette Zander; Sten Madsbad; Jan Lysgaard Madsen; Jens Juul Holst
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus.

Authors:  I M Welch; C Bruce; S E Hill; N W Read
Journal:  Clin Sci (Lond)       Date:  1987-02       Impact factor: 6.124

10.  Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients.

Authors:  J G Schwartz; D Guan; G M Green; W T Phillips
Journal:  Diabetes Care       Date:  1994-04       Impact factor: 19.112

View more
  7 in total

Review 1.  Treatment options for patients with severe gastroparesis.

Authors:  Hasse Abrahamsson
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 2.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 4.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 5.  Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies.

Authors:  Bing Pang; Qiang Zhou; Jun-Ling Li; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 6.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

7.  Case report: rare case of mechanical bowel obstruction due to strangulation by gastric stimulator electrodes.

Authors:  Hans Lederhuber; Stephan Axer; Christof Ihle
Journal:  BMC Surg       Date:  2015-03-30       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.